Evogene Ltd. (EVGN)
Uses AI to design better crops, medicines, and industrial materials.
$0.49-0.05%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-57.4%
The outlook
EVGN is trading near the lower end of its 52-week range and below both its 50- and 200-day moving averages, signaling a weak near-term trend. Analyst coverage leans bullish, with the average price target implying significant upside, though the overall score remains bearish at 23/100. The stock reflects substantial disagreement between longer-term targets and current momentum.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range11% of the way from its 52-week low to high
Price targetAvg target +335% vs current price
Market cap
$6.0M
52-wk high
$1.50
52-wk low
$0.37
50-day avg
$0.57
200-day avg
$0.89
Trailing P/E
—